Skip to content

NaturalisMS

Measuring the real-world impact of cognitive impairment in multiple sclerosis - NaturalisMS: Real-world impact of cognitive impairment in multiple sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58335
Enrollment
160
Registered
2025-07-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis Multiple Sclerosis

Interventions

None listed

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All people with multiple sclerosis and all controls who have previously participated in the “Amsterdam MS Cohort” (2020/269) and have provided interest in being contacted for follow-up study.

Exclusion criteria

Exclusion criteria: General exclusion criteria:PregnancyKnown contraindications for MRI investigations, such as the presence of metal objects (e.g., pacemaker, arteriovenous clips) or severe claustrophobia.A  neurological disorder other than multiple sclerosisIncapable of providing informed consent independentlyAdditional exclusion criteria for people with multiple sclerosisA relapse in the two months prior to participation

Design outcomes

Primary

MeasureTime frame
The main study parameters are brain network dynamics measured by mw-fMRI, cognitive performance quantified by extensively validated tests, and the impact on daily life determined by ecological sampling.

Secondary

MeasureTime frame
The secondary objectives explore how naturalistic measurements in people with multiple sclerosis (PwMS) relate to laboratory-based assessments. This includes: investigating the added value of mw-fMRI compared with rs-fMRI and establishing how fluctuations in mood, stress, and affect in daily life compare to questionnaires.

Countries

Netherlands

Contacts

Public ContactT. A. A. Broeders

Amsterdam UMC

t.broeders@amsterdamumc.nl+31 (0)20-4448040

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 7, 2026